nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—Procarbazine—brain cancer	0.767	1	CrCrCtD
Baclofen—SLC22A8—choroid plexus—brain cancer	0.0162	0.191	CbGeAlD
Baclofen—GABBR2—hindbrain—brain cancer	0.0112	0.133	CbGeAlD
Baclofen—GABBR2—brainstem—brain cancer	0.00645	0.076	CbGeAlD
Baclofen—GABBR2—telencephalon—brain cancer	0.00572	0.0675	CbGeAlD
Baclofen—GABBR2—medulla oblongata—brain cancer	0.00449	0.053	CbGeAlD
Baclofen—GABBR2—midbrain—brain cancer	0.00411	0.0484	CbGeAlD
Baclofen—GABBR2—spinal cord—brain cancer	0.00401	0.0473	CbGeAlD
Baclofen—GABBR2—endocrine gland—brain cancer	0.00361	0.0426	CbGeAlD
Baclofen—GABBR2—head—brain cancer	0.00356	0.042	CbGeAlD
Baclofen—GABBR2—central nervous system—brain cancer	0.00325	0.0383	CbGeAlD
Baclofen—GABBR2—cerebellum—brain cancer	0.00318	0.0375	CbGeAlD
Baclofen—GABBR1—telencephalon—brain cancer	0.00289	0.034	CbGeAlD
Baclofen—GABBR2—brain—brain cancer	0.00258	0.0304	CbGeAlD
Baclofen—GABBR1—pituitary gland—brain cancer	0.00235	0.0277	CbGeAlD
Baclofen—GABBR1—medulla oblongata—brain cancer	0.00227	0.0268	CbGeAlD
Baclofen—GABBR1—midbrain—brain cancer	0.00207	0.0244	CbGeAlD
Baclofen—GABBR1—spinal cord—brain cancer	0.00202	0.0239	CbGeAlD
Baclofen—GABBR1—cerebellum—brain cancer	0.0016	0.0189	CbGeAlD
Baclofen—Chlorpropamide—CYP2C9—brain cancer	0.0015	0.629	CrCbGaD
Baclofen—GABBR1—brain—brain cancer	0.0013	0.0154	CbGeAlD
Baclofen—Ibuprofen—CYP2C9—brain cancer	0.000883	0.371	CrCbGaD
Baclofen—SLC22A8—head—brain cancer	0.00071	0.00837	CbGeAlD
Baclofen—SLC22A8—central nervous system—brain cancer	0.000648	0.00764	CbGeAlD
Baclofen—SLC22A8—brain—brain cancer	0.000515	0.00607	CbGeAlD
Baclofen—Anxiety—Procarbazine—brain cancer	0.000344	0.00237	CcSEcCtD
Baclofen—Sweating increased—Temozolomide—brain cancer	0.000343	0.00236	CcSEcCtD
Baclofen—Dry mouth—Procarbazine—brain cancer	0.000337	0.00232	CcSEcCtD
Baclofen—Confusional state—Procarbazine—brain cancer	0.000333	0.0023	CcSEcCtD
Baclofen—Vomiting—Lomustine—brain cancer	0.000331	0.00228	CcSEcCtD
Baclofen—Oedema—Procarbazine—brain cancer	0.000331	0.00228	CcSEcCtD
Baclofen—Dysuria—Temozolomide—brain cancer	0.000329	0.00227	CcSEcCtD
Baclofen—Infection—Procarbazine—brain cancer	0.000329	0.00226	CcSEcCtD
Baclofen—Hyperglycaemia—Carmustine—brain cancer	0.000328	0.00226	CcSEcCtD
Baclofen—Angiopathy—Hydroxyurea—brain cancer	0.000327	0.00225	CcSEcCtD
Baclofen—Pneumonia—Carmustine—brain cancer	0.000326	0.00225	CcSEcCtD
Baclofen—Shock—Procarbazine—brain cancer	0.000325	0.00224	CcSEcCtD
Baclofen—Pollakiuria—Temozolomide—brain cancer	0.000325	0.00224	CcSEcCtD
Baclofen—Erectile dysfunction—Temozolomide—brain cancer	0.000324	0.00223	CcSEcCtD
Baclofen—Depression—Carmustine—brain cancer	0.000323	0.00223	CcSEcCtD
Baclofen—Chills—Hydroxyurea—brain cancer	0.000323	0.00223	CcSEcCtD
Baclofen—Tachycardia—Procarbazine—brain cancer	0.000323	0.00222	CcSEcCtD
Baclofen—Weight increased—Temozolomide—brain cancer	0.00032	0.0022	CcSEcCtD
Baclofen—Hyperhidrosis—Procarbazine—brain cancer	0.00032	0.0022	CcSEcCtD
Baclofen—Renal failure—Carmustine—brain cancer	0.000319	0.0022	CcSEcCtD
Baclofen—Alopecia—Hydroxyurea—brain cancer	0.000318	0.00219	CcSEcCtD
Baclofen—Weight decreased—Temozolomide—brain cancer	0.000318	0.00219	CcSEcCtD
Baclofen—Hyperglycaemia—Temozolomide—brain cancer	0.000317	0.00219	CcSEcCtD
Baclofen—Pneumonia—Temozolomide—brain cancer	0.000315	0.00217	CcSEcCtD
Baclofen—Anorexia—Procarbazine—brain cancer	0.000315	0.00217	CcSEcCtD
Baclofen—Depression—Temozolomide—brain cancer	0.000313	0.00215	CcSEcCtD
Baclofen—Nausea—Lomustine—brain cancer	0.000309	0.00213	CcSEcCtD
Baclofen—Hypotension—Procarbazine—brain cancer	0.000309	0.00213	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000301	0.00208	CcSEcCtD
Baclofen—Insomnia—Procarbazine—brain cancer	0.000299	0.00206	CcSEcCtD
Baclofen—Paraesthesia—Procarbazine—brain cancer	0.000297	0.00205	CcSEcCtD
Baclofen—Hepatobiliary disease—Temozolomide—brain cancer	0.000297	0.00204	CcSEcCtD
Baclofen—Somnolence—Procarbazine—brain cancer	0.000294	0.00203	CcSEcCtD
Baclofen—Ill-defined disorder—Hydroxyurea—brain cancer	0.000291	0.002	CcSEcCtD
Baclofen—Anaemia—Hydroxyurea—brain cancer	0.00029	0.002	CcSEcCtD
Baclofen—Hallucination—Carmustine—brain cancer	0.00029	0.002	CcSEcCtD
Baclofen—Hypoaesthesia—Carmustine—brain cancer	0.00029	0.002	CcSEcCtD
Baclofen—Decreased appetite—Procarbazine—brain cancer	0.000287	0.00198	CcSEcCtD
Baclofen—Oedema peripheral—Carmustine—brain cancer	0.000287	0.00198	CcSEcCtD
Baclofen—Connective tissue disorder—Carmustine—brain cancer	0.000286	0.00197	CcSEcCtD
Baclofen—Fatigue—Procarbazine—brain cancer	0.000285	0.00196	CcSEcCtD
Baclofen—Malaise—Hydroxyurea—brain cancer	0.000283	0.00195	CcSEcCtD
Baclofen—Constipation—Procarbazine—brain cancer	0.000283	0.00195	CcSEcCtD
Baclofen—Pain—Procarbazine—brain cancer	0.000283	0.00195	CcSEcCtD
Baclofen—Dysphagia—Etoposide—brain cancer	0.000281	0.00194	CcSEcCtD
Baclofen—Visual impairment—Carmustine—brain cancer	0.000281	0.00193	CcSEcCtD
Baclofen—Hypoaesthesia—Temozolomide—brain cancer	0.00028	0.00193	CcSEcCtD
Baclofen—Hallucination—Temozolomide—brain cancer	0.00028	0.00193	CcSEcCtD
Baclofen—Urinary tract disorder—Temozolomide—brain cancer	0.000278	0.00191	CcSEcCtD
Baclofen—Oedema peripheral—Temozolomide—brain cancer	0.000277	0.00191	CcSEcCtD
Baclofen—Connective tissue disorder—Temozolomide—brain cancer	0.000277	0.00191	CcSEcCtD
Baclofen—Urethral disorder—Temozolomide—brain cancer	0.000276	0.0019	CcSEcCtD
Baclofen—Sweating increased—Etoposide—brain cancer	0.000274	0.00189	CcSEcCtD
Baclofen—Feeling abnormal—Procarbazine—brain cancer	0.000273	0.00188	CcSEcCtD
Baclofen—Eye disorder—Carmustine—brain cancer	0.000272	0.00188	CcSEcCtD
Baclofen—Convulsion—Hydroxyurea—brain cancer	0.000272	0.00187	CcSEcCtD
Baclofen—Visual impairment—Temozolomide—brain cancer	0.000271	0.00187	CcSEcCtD
Baclofen—Gastrointestinal pain—Procarbazine—brain cancer	0.00027	0.00186	CcSEcCtD
Baclofen—Flushing—Carmustine—brain cancer	0.00027	0.00186	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000265	0.00183	CcSEcCtD
Baclofen—Discomfort—Hydroxyurea—brain cancer	0.000264	0.00182	CcSEcCtD
Baclofen—Eye disorder—Temozolomide—brain cancer	0.000263	0.00181	CcSEcCtD
Baclofen—Urticaria—Procarbazine—brain cancer	0.000263	0.00181	CcSEcCtD
Baclofen—Tinnitus—Temozolomide—brain cancer	0.000262	0.00181	CcSEcCtD
Baclofen—Abdominal pain—Procarbazine—brain cancer	0.000261	0.0018	CcSEcCtD
Baclofen—Body temperature increased—Procarbazine—brain cancer	0.000261	0.0018	CcSEcCtD
Baclofen—Cardiac disorder—Temozolomide—brain cancer	0.000261	0.0018	CcSEcCtD
Baclofen—Flushing—Temozolomide—brain cancer	0.000261	0.0018	CcSEcCtD
Baclofen—Arrhythmia—Carmustine—brain cancer	0.00026	0.00179	CcSEcCtD
Baclofen—Alopecia—Carmustine—brain cancer	0.000257	0.00177	CcSEcCtD
Baclofen—Oedema—Hydroxyurea—brain cancer	0.000256	0.00176	CcSEcCtD
Baclofen—Angiopathy—Temozolomide—brain cancer	0.000255	0.00176	CcSEcCtD
Baclofen—Mental disorder—Carmustine—brain cancer	0.000255	0.00176	CcSEcCtD
Baclofen—Infection—Hydroxyurea—brain cancer	0.000254	0.00175	CcSEcCtD
Baclofen—Mediastinal disorder—Temozolomide—brain cancer	0.000254	0.00175	CcSEcCtD
Baclofen—Malnutrition—Carmustine—brain cancer	0.000254	0.00175	CcSEcCtD
Baclofen—Chills—Temozolomide—brain cancer	0.000253	0.00174	CcSEcCtD
Baclofen—Pneumonia—Etoposide—brain cancer	0.000252	0.00174	CcSEcCtD
Baclofen—Nervous system disorder—Hydroxyurea—brain cancer	0.000251	0.00173	CcSEcCtD
Baclofen—Alopecia—Temozolomide—brain cancer	0.000249	0.00171	CcSEcCtD
Baclofen—Skin disorder—Hydroxyurea—brain cancer	0.000249	0.00171	CcSEcCtD
Baclofen—Renal failure—Etoposide—brain cancer	0.000247	0.0017	CcSEcCtD
Baclofen—Mental disorder—Temozolomide—brain cancer	0.000247	0.0017	CcSEcCtD
Baclofen—Back pain—Carmustine—brain cancer	0.000245	0.00169	CcSEcCtD
Baclofen—Malnutrition—Temozolomide—brain cancer	0.000245	0.00169	CcSEcCtD
Baclofen—Anorexia—Hydroxyurea—brain cancer	0.000244	0.00168	CcSEcCtD
Baclofen—Dysgeusia—Temozolomide—brain cancer	0.00024	0.00165	CcSEcCtD
Baclofen—Vision blurred—Carmustine—brain cancer	0.000239	0.00165	CcSEcCtD
Baclofen—Tremor—Carmustine—brain cancer	0.000238	0.00164	CcSEcCtD
Baclofen—Asthenia—Procarbazine—brain cancer	0.000237	0.00163	CcSEcCtD
Baclofen—Hepatobiliary disease—Etoposide—brain cancer	0.000237	0.00163	CcSEcCtD
Baclofen—Back pain—Temozolomide—brain cancer	0.000237	0.00163	CcSEcCtD
Baclofen—Anaemia—Carmustine—brain cancer	0.000234	0.00161	CcSEcCtD
Baclofen—Pruritus—Procarbazine—brain cancer	0.000234	0.00161	CcSEcCtD
Baclofen—Agitation—Carmustine—brain cancer	0.000233	0.00161	CcSEcCtD
Baclofen—Vision blurred—Temozolomide—brain cancer	0.000231	0.00159	CcSEcCtD
Baclofen—Tremor—Temozolomide—brain cancer	0.00023	0.00158	CcSEcCtD
Baclofen—Dyspnoea—Hydroxyurea—brain cancer	0.000228	0.00157	CcSEcCtD
Baclofen—Somnolence—Hydroxyurea—brain cancer	0.000228	0.00157	CcSEcCtD
Baclofen—Ill-defined disorder—Temozolomide—brain cancer	0.000227	0.00157	CcSEcCtD
Baclofen—Anaemia—Temozolomide—brain cancer	0.000226	0.00156	CcSEcCtD
Baclofen—Diarrhoea—Procarbazine—brain cancer	0.000226	0.00156	CcSEcCtD
Baclofen—Dyspepsia—Hydroxyurea—brain cancer	0.000225	0.00155	CcSEcCtD
Baclofen—Agitation—Temozolomide—brain cancer	0.000225	0.00155	CcSEcCtD
Baclofen—Hypoaesthesia—Etoposide—brain cancer	0.000224	0.00154	CcSEcCtD
Baclofen—Decreased appetite—Hydroxyurea—brain cancer	0.000222	0.00153	CcSEcCtD
Baclofen—Urinary tract disorder—Etoposide—brain cancer	0.000222	0.00153	CcSEcCtD
Baclofen—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000221	0.00152	CcSEcCtD
Baclofen—Malaise—Temozolomide—brain cancer	0.000221	0.00152	CcSEcCtD
Baclofen—Urethral disorder—Etoposide—brain cancer	0.000221	0.00152	CcSEcCtD
Baclofen—Fatigue—Hydroxyurea—brain cancer	0.000221	0.00152	CcSEcCtD
Baclofen—Vertigo—Temozolomide—brain cancer	0.00022	0.00152	CcSEcCtD
Baclofen—Convulsion—Carmustine—brain cancer	0.00022	0.00151	CcSEcCtD
Baclofen—Hypertension—Carmustine—brain cancer	0.000219	0.00151	CcSEcCtD
Baclofen—Pain—Hydroxyurea—brain cancer	0.000219	0.00151	CcSEcCtD
Baclofen—Constipation—Hydroxyurea—brain cancer	0.000219	0.00151	CcSEcCtD
Baclofen—Dizziness—Procarbazine—brain cancer	0.000219	0.00151	CcSEcCtD
Baclofen—Palpitations—Temozolomide—brain cancer	0.000217	0.00149	CcSEcCtD
Baclofen—Myalgia—Carmustine—brain cancer	0.000216	0.00149	CcSEcCtD
Baclofen—Chest pain—Carmustine—brain cancer	0.000216	0.00149	CcSEcCtD
Baclofen—Anxiety—Carmustine—brain cancer	0.000215	0.00148	CcSEcCtD
Baclofen—Convulsion—Temozolomide—brain cancer	0.000212	0.00146	CcSEcCtD
Baclofen—Hypertension—Temozolomide—brain cancer	0.000212	0.00146	CcSEcCtD
Baclofen—Feeling abnormal—Hydroxyurea—brain cancer	0.000211	0.00145	CcSEcCtD
Baclofen—Eye disorder—Etoposide—brain cancer	0.00021	0.00145	CcSEcCtD
Baclofen—Vomiting—Procarbazine—brain cancer	0.00021	0.00145	CcSEcCtD
Baclofen—Cardiac disorder—Etoposide—brain cancer	0.000209	0.00144	CcSEcCtD
Baclofen—Flushing—Etoposide—brain cancer	0.000209	0.00144	CcSEcCtD
Baclofen—Confusional state—Carmustine—brain cancer	0.000209	0.00144	CcSEcCtD
Baclofen—Myalgia—Temozolomide—brain cancer	0.000209	0.00144	CcSEcCtD
Baclofen—Rash—Procarbazine—brain cancer	0.000209	0.00144	CcSEcCtD
Baclofen—Dermatitis—Procarbazine—brain cancer	0.000208	0.00144	CcSEcCtD
Baclofen—Anxiety—Temozolomide—brain cancer	0.000208	0.00143	CcSEcCtD
Baclofen—Headache—Procarbazine—brain cancer	0.000207	0.00143	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000207	0.00143	CcSEcCtD
Baclofen—Oedema—Carmustine—brain cancer	0.000207	0.00143	CcSEcCtD
Baclofen—Discomfort—Temozolomide—brain cancer	0.000206	0.00142	CcSEcCtD
Baclofen—Infection—Carmustine—brain cancer	0.000206	0.00142	CcSEcCtD
Baclofen—Angiopathy—Etoposide—brain cancer	0.000204	0.00141	CcSEcCtD
Baclofen—Dry mouth—Temozolomide—brain cancer	0.000204	0.00141	CcSEcCtD
Baclofen—Mediastinal disorder—Etoposide—brain cancer	0.000203	0.0014	CcSEcCtD
Baclofen—Body temperature increased—Hydroxyurea—brain cancer	0.000202	0.00139	CcSEcCtD
Baclofen—Chills—Etoposide—brain cancer	0.000202	0.00139	CcSEcCtD
Baclofen—Tachycardia—Carmustine—brain cancer	0.000202	0.00139	CcSEcCtD
Baclofen—Confusional state—Temozolomide—brain cancer	0.000202	0.00139	CcSEcCtD
Baclofen—Oedema—Temozolomide—brain cancer	0.0002	0.00138	CcSEcCtD
Baclofen—Alopecia—Etoposide—brain cancer	0.000199	0.00137	CcSEcCtD
Baclofen—Infection—Temozolomide—brain cancer	0.000199	0.00137	CcSEcCtD
Baclofen—Anorexia—Carmustine—brain cancer	0.000197	0.00136	CcSEcCtD
Baclofen—Nausea—Procarbazine—brain cancer	0.000196	0.00135	CcSEcCtD
Baclofen—Nervous system disorder—Temozolomide—brain cancer	0.000196	0.00135	CcSEcCtD
Baclofen—Skin disorder—Temozolomide—brain cancer	0.000194	0.00134	CcSEcCtD
Baclofen—Hypotension—Carmustine—brain cancer	0.000193	0.00133	CcSEcCtD
Baclofen—Hyperhidrosis—Temozolomide—brain cancer	0.000193	0.00133	CcSEcCtD
Baclofen—Dysgeusia—Etoposide—brain cancer	0.000192	0.00132	CcSEcCtD
Baclofen—Anorexia—Temozolomide—brain cancer	0.000191	0.00131	CcSEcCtD
Baclofen—Back pain—Etoposide—brain cancer	0.00019	0.00131	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Carmustine—brain cancer	0.000189	0.0013	CcSEcCtD
Baclofen—Insomnia—Carmustine—brain cancer	0.000187	0.00129	CcSEcCtD
Baclofen—Paraesthesia—Carmustine—brain cancer	0.000186	0.00128	CcSEcCtD
Baclofen—Dyspnoea—Carmustine—brain cancer	0.000184	0.00127	CcSEcCtD
Baclofen—Somnolence—Carmustine—brain cancer	0.000184	0.00127	CcSEcCtD
Baclofen—Asthenia—Hydroxyurea—brain cancer	0.000184	0.00127	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000182	0.00126	CcSEcCtD
Baclofen—Ill-defined disorder—Etoposide—brain cancer	0.000182	0.00125	CcSEcCtD
Baclofen—Anaemia—Etoposide—brain cancer	0.000181	0.00125	CcSEcCtD
Baclofen—Insomnia—Temozolomide—brain cancer	0.000181	0.00125	CcSEcCtD
Baclofen—Decreased appetite—Carmustine—brain cancer	0.00018	0.00124	CcSEcCtD
Baclofen—Paraesthesia—Temozolomide—brain cancer	0.00018	0.00124	CcSEcCtD
Baclofen—Gastrointestinal disorder—Carmustine—brain cancer	0.000179	0.00123	CcSEcCtD
Baclofen—Dyspnoea—Temozolomide—brain cancer	0.000178	0.00123	CcSEcCtD
Baclofen—Somnolence—Temozolomide—brain cancer	0.000178	0.00122	CcSEcCtD
Baclofen—Pain—Carmustine—brain cancer	0.000177	0.00122	CcSEcCtD
Baclofen—Constipation—Carmustine—brain cancer	0.000177	0.00122	CcSEcCtD
Baclofen—Malaise—Etoposide—brain cancer	0.000177	0.00122	CcSEcCtD
Baclofen—Vertigo—Etoposide—brain cancer	0.000176	0.00121	CcSEcCtD
Baclofen—Dyspepsia—Temozolomide—brain cancer	0.000176	0.00121	CcSEcCtD
Baclofen—Diarrhoea—Hydroxyurea—brain cancer	0.000175	0.00121	CcSEcCtD
Baclofen—Decreased appetite—Temozolomide—brain cancer	0.000174	0.0012	CcSEcCtD
Baclofen—Gastrointestinal disorder—Temozolomide—brain cancer	0.000173	0.00119	CcSEcCtD
Baclofen—Fatigue—Temozolomide—brain cancer	0.000172	0.00119	CcSEcCtD
Baclofen—Loss of consciousness—Etoposide—brain cancer	0.000172	0.00119	CcSEcCtD
Baclofen—Pain—Temozolomide—brain cancer	0.000171	0.00118	CcSEcCtD
Baclofen—Constipation—Temozolomide—brain cancer	0.000171	0.00118	CcSEcCtD
Baclofen—Feeling abnormal—Carmustine—brain cancer	0.000171	0.00117	CcSEcCtD
Baclofen—Convulsion—Etoposide—brain cancer	0.00017	0.00117	CcSEcCtD
Baclofen—Hypertension—Etoposide—brain cancer	0.000169	0.00117	CcSEcCtD
Baclofen—Dizziness—Hydroxyurea—brain cancer	0.000169	0.00117	CcSEcCtD
Baclofen—Gastrointestinal pain—Carmustine—brain cancer	0.000169	0.00117	CcSEcCtD
Baclofen—Chest pain—Etoposide—brain cancer	0.000167	0.00115	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000166	0.00114	CcSEcCtD
Baclofen—Discomfort—Etoposide—brain cancer	0.000165	0.00114	CcSEcCtD
Baclofen—Feeling abnormal—Temozolomide—brain cancer	0.000165	0.00114	CcSEcCtD
Baclofen—Abdominal pain—Carmustine—brain cancer	0.000164	0.00113	CcSEcCtD
Baclofen—Body temperature increased—Carmustine—brain cancer	0.000164	0.00113	CcSEcCtD
Baclofen—Gastrointestinal pain—Temozolomide—brain cancer	0.000164	0.00113	CcSEcCtD
Baclofen—Vomiting—Hydroxyurea—brain cancer	0.000163	0.00112	CcSEcCtD
Baclofen—Rash—Hydroxyurea—brain cancer	0.000161	0.00111	CcSEcCtD
Baclofen—Confusional state—Etoposide—brain cancer	0.000161	0.00111	CcSEcCtD
Baclofen—Dermatitis—Hydroxyurea—brain cancer	0.000161	0.00111	CcSEcCtD
Baclofen—Headache—Hydroxyurea—brain cancer	0.00016	0.0011	CcSEcCtD
Baclofen—Infection—Etoposide—brain cancer	0.000159	0.0011	CcSEcCtD
Baclofen—Urticaria—Temozolomide—brain cancer	0.000159	0.00109	CcSEcCtD
Baclofen—Abdominal pain—Temozolomide—brain cancer	0.000158	0.00109	CcSEcCtD
Baclofen—Body temperature increased—Temozolomide—brain cancer	0.000158	0.00109	CcSEcCtD
Baclofen—Tachycardia—Etoposide—brain cancer	0.000156	0.00108	CcSEcCtD
Baclofen—Skin disorder—Etoposide—brain cancer	0.000155	0.00107	CcSEcCtD
Baclofen—Hyperhidrosis—Etoposide—brain cancer	0.000155	0.00107	CcSEcCtD
Baclofen—Anorexia—Etoposide—brain cancer	0.000153	0.00105	CcSEcCtD
Baclofen—Nausea—Hydroxyurea—brain cancer	0.000152	0.00105	CcSEcCtD
Baclofen—Hypotension—Etoposide—brain cancer	0.00015	0.00103	CcSEcCtD
Baclofen—Asthenia—Carmustine—brain cancer	0.000148	0.00102	CcSEcCtD
Baclofen—Paraesthesia—Etoposide—brain cancer	0.000144	0.00099	CcSEcCtD
Baclofen—Asthenia—Temozolomide—brain cancer	0.000143	0.000988	CcSEcCtD
Baclofen—Dyspnoea—Etoposide—brain cancer	0.000143	0.000983	CcSEcCtD
Baclofen—Somnolence—Etoposide—brain cancer	0.000142	0.00098	CcSEcCtD
Baclofen—Diarrhoea—Carmustine—brain cancer	0.000142	0.000975	CcSEcCtD
Baclofen—Pruritus—Temozolomide—brain cancer	0.000141	0.000975	CcSEcCtD
Baclofen—Decreased appetite—Etoposide—brain cancer	0.000139	0.000958	CcSEcCtD
Baclofen—Gastrointestinal disorder—Etoposide—brain cancer	0.000138	0.000952	CcSEcCtD
Baclofen—Fatigue—Etoposide—brain cancer	0.000138	0.00095	CcSEcCtD
Baclofen—Dizziness—Carmustine—brain cancer	0.000137	0.000943	CcSEcCtD
Baclofen—Pain—Etoposide—brain cancer	0.000137	0.000943	CcSEcCtD
Baclofen—Constipation—Etoposide—brain cancer	0.000137	0.000943	CcSEcCtD
Baclofen—Diarrhoea—Temozolomide—brain cancer	0.000137	0.000943	CcSEcCtD
Baclofen—Dizziness—Temozolomide—brain cancer	0.000132	0.000911	CcSEcCtD
Baclofen—Feeling abnormal—Etoposide—brain cancer	0.000132	0.000908	CcSEcCtD
Baclofen—Vomiting—Carmustine—brain cancer	0.000132	0.000906	CcSEcCtD
Baclofen—Gastrointestinal pain—Etoposide—brain cancer	0.000131	0.000901	CcSEcCtD
Baclofen—Rash—Carmustine—brain cancer	0.00013	0.000899	CcSEcCtD
Baclofen—Dermatitis—Carmustine—brain cancer	0.00013	0.000898	CcSEcCtD
Baclofen—Headache—Carmustine—brain cancer	0.00013	0.000893	CcSEcCtD
Baclofen—Vomiting—Temozolomide—brain cancer	0.000127	0.000876	CcSEcCtD
Baclofen—Urticaria—Etoposide—brain cancer	0.000127	0.000876	CcSEcCtD
Baclofen—Abdominal pain—Etoposide—brain cancer	0.000126	0.000871	CcSEcCtD
Baclofen—Body temperature increased—Etoposide—brain cancer	0.000126	0.000871	CcSEcCtD
Baclofen—Rash—Temozolomide—brain cancer	0.000126	0.000869	CcSEcCtD
Baclofen—Dermatitis—Temozolomide—brain cancer	0.000126	0.000868	CcSEcCtD
Baclofen—Headache—Temozolomide—brain cancer	0.000125	0.000863	CcSEcCtD
Baclofen—Nausea—Carmustine—brain cancer	0.000123	0.000847	CcSEcCtD
Baclofen—Nausea—Temozolomide—brain cancer	0.000119	0.000818	CcSEcCtD
Baclofen—Asthenia—Etoposide—brain cancer	0.000115	0.000791	CcSEcCtD
Baclofen—Pruritus—Etoposide—brain cancer	0.000113	0.00078	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—brain cancer	0.000109	0.000754	CcSEcCtD
Baclofen—Dizziness—Etoposide—brain cancer	0.000106	0.000729	CcSEcCtD
Baclofen—Vomiting—Etoposide—brain cancer	0.000102	0.000701	CcSEcCtD
Baclofen—Rash—Etoposide—brain cancer	0.000101	0.000695	CcSEcCtD
Baclofen—Dermatitis—Etoposide—brain cancer	0.000101	0.000694	CcSEcCtD
Baclofen—Headache—Etoposide—brain cancer	0.0001	0.000691	CcSEcCtD
Baclofen—Nausea—Etoposide—brain cancer	9.5e-05	0.000655	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—PTCH2—brain cancer	3.81e-05	0.0403	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—OR14C36—brain cancer	3.34e-05	0.0353	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—OR4C12—brain cancer	3.34e-05	0.0353	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—OR14C36—brain cancer	3.03e-05	0.0321	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—OR4C12—brain cancer	3.03e-05	0.0321	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTCH2—brain cancer	2.45e-05	0.026	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—OR4C12—brain cancer	2.15e-05	0.0228	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—OR14C36—brain cancer	2.15e-05	0.0228	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—SHH—brain cancer	1.96e-05	0.0208	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTCH2—brain cancer	1.95e-05	0.0207	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OR14C36—brain cancer	1.95e-05	0.0207	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—OR4C12—brain cancer	1.95e-05	0.0207	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—PTCH1—brain cancer	1.86e-05	0.0197	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—SMO—brain cancer	1.86e-05	0.0197	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—OR4C12—brain cancer	1.79e-05	0.019	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—OR14C36—brain cancer	1.79e-05	0.019	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—ABR—brain cancer	1.69e-05	0.0179	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ABR—brain cancer	1.53e-05	0.0162	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DTX2—brain cancer	1.52e-05	0.0161	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—SHH—brain cancer	1.26e-05	0.0134	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTCH2—brain cancer	1.26e-05	0.0133	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTCH1—brain cancer	1.2e-05	0.0127	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—SMO—brain cancer	1.2e-05	0.0127	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—OR4C12—brain cancer	1.15e-05	0.0122	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTCH2—brain cancer	1.15e-05	0.0122	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—OR14C36—brain cancer	1.15e-05	0.0122	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HES5—brain cancer	1.12e-05	0.0118	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ABR—brain cancer	1.09e-05	0.0115	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STRADA—brain cancer	1.09e-05	0.0115	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—TRPC6—brain cancer	1.07e-05	0.0113	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—SHH—brain cancer	1.01e-05	0.0107	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ABR—brain cancer	9.88e-06	0.0105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DTX2—brain cancer	9.81e-06	0.0104	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—TRPC6—brain cancer	9.7e-06	0.0103	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—SMO—brain cancer	9.54e-06	0.0101	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTCH1—brain cancer	9.54e-06	0.0101	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	9.38e-06	0.00993	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ABR—brain cancer	9.06e-06	0.00959	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GLI2—brain cancer	8.75e-06	0.00926	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GLI1—brain cancer	8.22e-06	0.00871	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—VAV1—brain cancer	8.01e-06	0.00848	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SUFU—brain cancer	7.8e-06	0.00825	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GFAP—brain cancer	7.52e-06	0.00796	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTCH2—brain cancer	7.44e-06	0.00787	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—VAV1—brain cancer	7.27e-06	0.0077	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HES5—brain cancer	7.2e-06	0.00762	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HEY1—brain cancer	7.13e-06	0.00755	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STRADA—brain cancer	6.99e-06	0.0074	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DLL1—brain cancer	6.99e-06	0.0074	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—TRPC6—brain cancer	6.89e-06	0.00729	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SHH—brain cancer	6.49e-06	0.00687	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—TRPC6—brain cancer	6.25e-06	0.00662	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SMO—brain cancer	6.15e-06	0.00651	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTCH1—brain cancer	6.15e-06	0.00651	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SHH—brain cancer	5.95e-06	0.00629	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ABR—brain cancer	5.84e-06	0.00618	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TRPC6—brain cancer	5.73e-06	0.00607	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTCH1—brain cancer	5.64e-06	0.00597	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SMO—brain cancer	5.64e-06	0.00597	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLI2—brain cancer	5.64e-06	0.00597	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLI1—brain cancer	5.3e-06	0.00561	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—VAV1—brain cancer	5.16e-06	0.00546	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—brain cancer	5.08e-06	0.00538	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SUFU—brain cancer	5.02e-06	0.00532	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GFAP—brain cancer	4.85e-06	0.00513	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—VAV1—brain cancer	4.69e-06	0.00496	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—brain cancer	4.62e-06	0.00489	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HEY1—brain cancer	4.59e-06	0.00486	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DLL1—brain cancer	4.51e-06	0.00477	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH2—brain cancer	4.51e-06	0.00477	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	4.33e-06	0.00458	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VAV1—brain cancer	4.3e-06	0.00455	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SHH—brain cancer	3.83e-06	0.00406	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HES1—brain cancer	3.69e-06	0.00391	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TRPC6—brain cancer	3.69e-06	0.00391	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTCH1—brain cancer	3.63e-06	0.00384	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SMO—brain cancer	3.63e-06	0.00384	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—brain cancer	3.58e-06	0.00379	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFRA—brain cancer	3.52e-06	0.00372	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—brain cancer	3.41e-06	0.00361	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—brain cancer	3.28e-06	0.00347	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—brain cancer	3.25e-06	0.00344	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS2—brain cancer	3.09e-06	0.00327	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—brain cancer	2.97e-06	0.00315	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH2—brain cancer	2.9e-06	0.00307	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VAV1—brain cancer	2.77e-06	0.00293	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—brain cancer	2.73e-06	0.00289	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—brain cancer	2.73e-06	0.00289	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—brain cancer	2.48e-06	0.00263	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HES1—brain cancer	2.38e-06	0.00252	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—brain cancer	2.31e-06	0.00244	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRA—brain cancer	2.27e-06	0.0024	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPP1—brain cancer	2.2e-06	0.00233	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RELA—brain cancer	2.13e-06	0.00226	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—brain cancer	2.12e-06	0.00224	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—brain cancer	2.09e-06	0.00222	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS2—brain cancer	1.99e-06	0.00211	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—brain cancer	1.92e-06	0.00203	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCND1—brain cancer	1.87e-06	0.00198	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—brain cancer	1.85e-06	0.00196	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—brain cancer	1.76e-06	0.00186	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—brain cancer	1.76e-06	0.00186	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—brain cancer	1.63e-06	0.00173	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—brain cancer	1.61e-06	0.00171	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—brain cancer	1.6e-06	0.0017	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—brain cancer	1.5e-06	0.00159	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—brain cancer	1.47e-06	0.00155	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RELA—brain cancer	1.37e-06	0.00145	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—brain cancer	1.36e-06	0.00144	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—brain cancer	1.24e-06	0.00131	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—brain cancer	1.23e-06	0.0013	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—brain cancer	1.21e-06	0.00128	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—brain cancer	1.19e-06	0.00126	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—brain cancer	1.05e-06	0.00111	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—brain cancer	1.04e-06	0.0011	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—brain cancer	9.67e-07	0.00102	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—brain cancer	9.46e-07	0.001	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—brain cancer	7.94e-07	0.000841	CbGpPWpGaD
